Trademark Search  /  NEUROPRO

NEUROPRO

○ Dead · Abandoned

U.S. federal trademark · Serial No. 85872878

Mark
NEUROPRO
Status
Abandoned
Serial Number
85872878
Filing Date
September 11, 2012
Class(es)
Class 005

Owner

Neurodyn Inc.
03 · Vancouver, BC, CA

Goods & Services

Herbal supplements containing ginseng and ginsenocides, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginseng, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginseng and omega-3 fatty acids, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginsenocides, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginsenocides and omega-3 fatty acids, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginseng extract, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; Nutritional supplements containing ginseng extract and omega-3 fatty acids, in tablet, capsule, gel, powder or liquid form, for both the prevention and treatment of neurodegenerative diseases, namely, Parkinson's disease, Alzheimer's disease, and Amyotrophic lateral sclerosis, and the treatment of spinal cord injury, brain injury, promotion and maintenance of healthy neurons, memory, and cognitive function; medical food supplements in powdered, liquid and tablet form for the prevention and treatment of neurodegenerative disease, Alzheimer's disease, Parkinson's disease, and Amyotrophic lateral sclerosis; medical food for the treatment of spinal cord injury and brain injury; medical food supplements in powdered, liquid and tablet form; medical food supplements in powdered, liquid and tablet form for use in the dietary management of patients with neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis, spinal cord injury, and brain injury; ginseng, ginsenocides and omega-3 fatty acids for the dietary management of neurodegenerative disease, Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis, spinal cord injury, and brain injury

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "NEUROPRO" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.